Eric Dunbar is an associate in the Intellectual Property group in Axinn’s New York office. His practice focuses on litigation, primarily focusing on patent infringement suits related to medical devices and generic pharmaceutical products under the Hatch-Waxman Act. He received his law degree from Boston University School of Law, where he served as a Note Editor for the American Journal of Law and Medicine and as President of the Intellectual Property Law Society.
During law school, Eric was a summer associate with Axinn in 2017, a judicial intern for the Hon. M. Page Kelley in the United States District Court for the District of Massachusetts, a research assistant for Prof. Kristin Collins, a member of the Oxford Intellectual Property Law Moot Court team, and a member of the Legislative Policy and Drafting Clinic. He graduated from the University of Chicago in 2015 with a dual degree in Biology, with a concentration in Neuroscience, and Public Policy, with a concentration in Biopsychology.
- New York Intellectual Property Law Association
- American Intellectual Property Law Association
- New York State Bar Association
- American Bar Association
- IP and Collaboration, Pharmaceutical Executive, March 11, 2021
- Axinn FDA Update: Insights on the MODERN Labeling Act, Axinn Update, November 20, 2020
- Axinn IP Update: Prosecution Counsel Beware: Statutory Bars and Inequitable Conduct, Axinn Update, March 19, 2020
- 3 Strategies to Manage Case Scope in ANDA Patent Litigation, Law360, December 10, 2019
- Status Quo Maintained: FDA Reverses Course on Generic Product Labeling, FDLI Update, March 1, 2019
- JD – Boston University School of Law (2018)
- BA, General Honors – University of Chicago (2015)
- New York
- US District Court Southern District of New York
- US District Court Eastern District of New York